Back

A multi-database based ceRNA regulatory network for gastric cancer prognosis

yin, l.; Li, Q.

2023-08-04 gastroenterology
10.1101/2023.08.01.23293496 medRxiv
Show abstract

ObjectiveCircular RNA(circRNA) is a kind of endogenous non-coding RNA, which may be related to the occurrence and development of cancer. Based on the GEO database, this paper constructs a circRNA as a competitive endogenous RNAs(ceRNAs) that binds with microRNAs (miRNAs) to affect and regulate the expression of target genes. The ceRNA regulatory network based on circRNA-miRNA-mRNA model plays an important role in tumor prognosis and treatment. This paper explores the mechanism of circRNA-related ceRNA regulatory network in gastric cancer. MethodCircRNA, miRNA and mRNA data sets related to gastric cancer were downloaded from The Gene Expression Omnibus (GEO), and the limma package of R software (R 4.2.1 version) was used to identify the differences between gastric cancer tissues and adjacent normal tissues of gastric cancer. DEcircRNA, DEmiRNAs, and DEmRNAs. Based on circBase database, we explored the interactions among circRNA, miRNA and mRNA, and constructed the circRNA-miRNA-mRNA ceRNA network by using Cytoscape_v3.8.0. Then KEGG, GO and survival analysis of ceRNA-related genes were performed. Then, the prognostic data of gastric cancer were extracted from the TCGA database to construct the prognostic subnetwork of gastric cancer. ResultsKEGG analysis of ceRNAs mRNA showed that the pathway was mainly enriched in IL-17 signaling pathway, TNF signaling pathway and so on, which affected the prognosis of gastric cancer. hsa_circ_0055521/hsa-miR-204-5p/FAP, (hsa_circ_0005051, hsa_circ_0007613, hsa_circ_0045602, hsa_circ_0034398, hsa_circ_0006089) /hsa-miR-32-3p/FNDC1 were the ceRNA networks related to the prognosis of gastric cancer collaterals. ConclusionThis study found that IL-17 signaling pathway and TNF signaling pathway may affect the occurrence, development and prognosis of gastric cancer. And hsa_circ_0055521/hsa-miR-204-5p/FAP, (hsa_circ_0005051, hsa_circ_0007613, hsa_circ_0045602, hsa_circ_0034398, hsa_circ_0006089) /hsa-miR-32-3p/FNDC1 two circrNa-based stomachs The cancer ceRNA prognostic network is a new prognostic related ceRNA network for gastric cancer. FNDC1 and FAP may be potential therapeutic targets for gastric cancer.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Biomedicines
66 papers in training set
Top 0.1%
12.5%
2
PLOS ONE
4510 papers in training set
Top 18%
10.2%
3
PeerJ
261 papers in training set
Top 0.4%
6.9%
4
Frontiers in Medicine
113 papers in training set
Top 0.8%
4.9%
5
Heliyon
146 papers in training set
Top 0.2%
4.4%
6
BMC Cancer
52 papers in training set
Top 0.5%
4.0%
7
Frontiers in Oncology
95 papers in training set
Top 0.9%
4.0%
8
Frontiers in Pharmacology
100 papers in training set
Top 0.9%
3.6%
50% of probability mass above
9
Scientific Reports
3102 papers in training set
Top 35%
3.6%
10
Genes
126 papers in training set
Top 0.4%
2.8%
11
Bioscience Reports
25 papers in training set
Top 0.3%
2.6%
12
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 2%
2.4%
13
F1000Research
79 papers in training set
Top 1%
1.9%
14
Journal of Personalized Medicine
28 papers in training set
Top 0.3%
1.8%
15
BioMed Research International
25 papers in training set
Top 2%
1.7%
16
Medicine
30 papers in training set
Top 1%
1.7%
17
Biomolecules
95 papers in training set
Top 0.5%
1.7%
18
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 5%
1.5%
19
Frontiers in Physiology
93 papers in training set
Top 3%
1.5%
20
Journal of Translational Medicine
46 papers in training set
Top 1%
1.3%
21
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.2%
22
Informatics in Medicine Unlocked
21 papers in training set
Top 0.7%
1.2%
23
Cureus
67 papers in training set
Top 3%
1.2%
24
Aging
69 papers in training set
Top 2%
1.2%
25
Contemporary Clinical Trials Communications
11 papers in training set
Top 0.3%
1.2%
26
Frontiers in Microbiology
375 papers in training set
Top 7%
1.1%
27
Cell Death & Disease
126 papers in training set
Top 2%
0.9%
28
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 6%
0.8%
29
Epigenomics
10 papers in training set
Top 0.1%
0.7%
30
Frontiers in Immunology
586 papers in training set
Top 9%
0.7%